Michel Gilliet Selected Research

Peptides (Polypeptides)

3/2011	Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus.
12/2010	Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons.
7/2008	Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis.
7/2003	Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michel Gilliet Research Topics

Disease

23	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 12/2004
13	Neoplasms (Cancer) 01/2022 - 02/2003
11	Infections 01/2024 - 05/2003
10	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 10/2007
5	Inflammation (Inflammations) 01/2024 - 06/2006
4	Wounds and Injuries (Trauma) 10/2023 - 12/2010
4	Bites and Stings (Sting) 01/2022 - 11/2012
4	Melanoma (Melanoma, Malignant) 01/2020 - 07/2003
3	Basal Cell Carcinoma (Rodent Ulcer) 01/2023 - 08/2005
3	Allergic Contact Dermatitis 01/2023 - 11/2022
2	COVID-19 08/2023 - 01/2022
2	Vasculitis (Vasculitides) 08/2023 - 04/2016
2	Virus Diseases (Viral Diseases) 08/2023 - 08/2008
2	Skin Neoplasms (Skin Cancer) 01/2023 - 08/2005
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2020 - 03/2011
2	Skin Diseases (Skin Disease) 04/2019 - 09/2014
2	Cutaneous Lupus Erythematosus 02/2009 - 05/2005
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 08/2005 - 02/2003
1	Contact Dermatitis (Eczema, Contact) 10/2023
1	Dysbiosis 01/2023
1	Rosacea (Acne Rosacea) 01/2023
1	Chilblains (Chilblain) 03/2021
1	Rheumatoid Arthritis 05/2020
1	Communicable Diseases (Infectious Diseases) 05/2020
1	Pityriasis Rubra Pilaris 04/2017
1	Multiple Myeloma 01/2017
1	Bullous Pemphigoid (Pemphigoid) 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Reinfection 04/2016

Drug/Important Bio-Agent (IBA)

9	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2007
8	CytokinesIBA 05/2024 - 07/2003
8	Antimicrobial PeptidesIBA 07/2015 - 10/2007
7	Interferon Type IIBA 01/2022 - 12/2004
6	Proteins (Proteins, Gene)FDA Link 08/2023 - 07/2003
5	ChemokinesIBA 05/2024 - 02/2003
5	InterferonsIBA 01/2022 - 05/2006
4	Nucleic AcidsIBA 09/2014 - 08/2008
4	Peptides (Polypeptides)IBA 03/2011 - 07/2003
3	AntibodiesIBA 05/2020 - 09/2012
3	InterleukinsIBA 04/2017 - 09/2015
3	Imiquimod (Aldara)FDA LinkGeneric 01/2017 - 12/2004
3	AutoantigensIBA 03/2015 - 03/2011
2	Interleukin-17 (Interleukin 17)IBA 01/2023 - 04/2016
2	activin AIBA 01/2023 - 01/2022
2	CathelicidinsIBA 01/2023 - 12/2010
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022 - 12/2015
2	Monoclonal AntibodiesIBA 05/2020 - 02/2018
2	Toll-Like Receptor 9IBA 01/2019 - 10/2007
2	Messenger RNA (mRNA)IBA 04/2017 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 11/2012
2	RNA (Ribonucleic Acid)IBA 02/2016 - 08/2009
2	Antiviral Agents (Antivirals)IBA 02/2016 - 08/2008
2	Adenosine Monophosphate (AMP)IBA 12/2015 - 12/2014
2	Antimicrobial Cationic PeptidesIBA 08/2009 - 08/2008
2	Interferon-alpha (Interferon Alfa)IBA 11/2005 - 07/2005
1	Interleukin-1 (Interleukin 1)IBA 05/2024
1	phenylmercury borateIBA 10/2023
1	Local Anti-Infective Agents (Antiseptics)IBA 10/2023
1	OxidesIBA 10/2023
1	benzoxonium chlorideIBA 10/2023
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 10/2023
1	SARS-CoV-2 spike proteinIBA 08/2023
1	1,2-pentanediolIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	AcidsIBA 01/2023
1	CosmeticsIBA 01/2023
1	Kallikreins (Kallikrein)IBA 01/2023
1	cemiplimabIBA 01/2023
1	dexpanthenol (panthenol)FDA Link 11/2022
1	pantolactoneIBA 11/2022
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Chemokine CXCL10IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	NivolumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	AntigensIBA 01/2019
1	DNA receptor (receptor, DNA)IBA 01/2019
1	Fibronectins (Fibronectin)IBA 11/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2018
1	IntegrinsIBA 11/2018
1	Drug CombinationsIBA 01/2018
1	haloprogin FDA Link 01/2018
1	Antifungal AgentsIBA 01/2018
1	RAPTA-TIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Ustekinumab (CNTO 1275)FDA Link 04/2017
1	S100 Calcium Binding Protein A7IBA 01/2017
1	Inositol (Myoinositol)IBA 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	EnzymesIBA 01/2017
1	Histone MethyltransferasesIBA 01/2017
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017
1	X-Box Binding Protein 1IBA 01/2017
1	Nelfinavir (Viracept)FDA Link 10/2016
1	Interleukin-17 ReceptorsIBA 04/2016

Therapy/Procedure

13	Therapeutics 01/2022 - 04/2004
2	Immunotherapy 01/2023 - 12/2015
1	Precision Medicine 04/2019
1	Heterologous Transplantation (Xenotransplantation) 01/2017